First Wave BioPharma News

First Wave BioPharma Analyst Ratings

BenzingaMar 25 18:42

First Wave BioPharma Analyst Ratings

BenzingaMar 15 21:47

Roth MKM Maintains Buy on First Wave BioPharma, Lowers Price Target to $36

BenzingaMar 15 21:49

Roth MKM Maintains Buy on First Wave BioPharma, Adjusts Price Target To $40

BenzingaJan 4 02:16

Buy Rating Affirmed for First Wave BioPharma Amid Strategic Focus on Celiac Treatment

TipRanksJan 3 05:55

Roth MKM Reiterates Buy on First Wave BioPharma, Maintains $11 Price Target

BenzingaSep 19, 2023 21:23

First Wave BioPharma Analyst Ratings

BenzingaSep 19, 2023 21:22

First Wave BioPharma Analyst Ratings

BenzingaJul 14, 2023 18:15

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $10 Price Target

BenzingaJun 29, 2023 18:14

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $10 Price Target

BenzingaJun 13, 2023 22:48

HC Wainwright Adjusts First Wave BioPharma Price Target to $10 From $14, Maintains Buy Rating

MT NewswiresMay 15, 2023 19:41

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Lowers Price Target to $10

BenzingaMay 15, 2023 18:43

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $14 Price Target

BenzingaApr 26, 2023 18:16

HC Wainwright & Co. Maintains Buy on First Wave BioPharma, Lowers Price Target to $14

BenzingaApr 5, 2023 18:35

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target

BenzingaMar 9, 2023 22:00

First Wave BioPharma Analyst Ratings

Benzinga Analyst RatingsFeb 3, 2023 19:11

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target

Benzinga Real-time NewsFeb 3, 2023 19:11

First Wave BioPharma Analyst Ratings

Benzinga Analyst RatingsFeb 1, 2023 00:42

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target

Benzinga Real-time NewsFeb 1, 2023 00:41

First Wave BioPharma Analyst Ratings

Benzinga Analyst RatingsJan 27, 2023 02:29